Mechanistically, maladaptive trained immunity in IBD involves chronic activation of NOD2, TLR4, and IL-1R signaling, which continuously fuels the mTOR–HIF1α metabolic axis and sustains glycolysis and cholesterol biosynthesis [6,12,26,37,38]. This evidence concerns the gene MTOR and irritable bowel syndrome.